1 results match your criteria: "Nanjing University of Chinese Medicine Nanjing 210003 China wghongxia@sina.com +86-13851507368.[Affiliation]"

In recent years, with the rapid development of point-of-care testing, the application of lateral flow immunochromatography assay (LFIA) has become increasingly widespread. The key to the success of these detection technologies is the effective binding with diagnostic materials and detection antibody proteins. Although many researchers have tried to optimize antibody binding, a universally accepted strategy that can provide maximum performance has not been determined.

View Article and Find Full Text PDF